IP Library Granted Patent US 9,575,066
Granted Patent B2
US 9,575,066 · App. 14/108,236 · Granted Feb 21, 2017

Antibody-based arrays for detecting multiple signal transducers in rare circulating cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,575,066
App. No.
14/108,236
Granted
Feb 21, 2017
Kind
B2
Abstract

The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies.

Claims (22)

1. A kit for performing an antibody-based array method, the kit comprising:

(a) a dilution series of a plurality of capture antibodies restrained on a solid support;

(b) a plurality of detection antibodies comprising activation state-independent antibodies and activation state-dependent antibodies, wherein the detection antibodies comprise: a plurality of activation state-independent antibodies which are labeled with glucose oxidase, and a plurality of activation state-dependent antibodies labeled with a first member of a signal amplification pair, wherein the first member of the signal amplification pair is a peroxidase, wherein glucose oxidase generates hydrogen peroxide (H 2 O 2 ), which channels to and reacts with the first member of the signal amplification pair; and

(c) instructions for methods of using the kit to detect the activation states of a plurality of signal transduction molecules.

2. The kit of claim 1 , wherein the activation state-independent antibodies further comprise a detectable moiety, wherein said detectable moiety is a fluorophore.

3. The kit of claim 1 , wherein the activation state-independent antibodies are directly labeled with glucose oxidase.

4. The kit of claim 1 , wherein the kit further comprises first and second members of the signal amplification pair.

5. The kit of claim 4 , wherein the activation state-dependent antibodies are directly labeled with the first member of the signal amplification pair.

6. The kit of claim 1 , wherein the array has superior dynamic range, which comprises a plurality of dilution series of capture antibodies specific for one or more analytes in a cellular extract.

7. The kit of claim 6 , wherein the cellular extract comprises an extract of circulating cells of a solid tumor.

8. The kit of claim 7 , wherein the cells are isolated from a patient sample by immunomagnetic separation.

9. The kit of claim 8 , wherein the patient sample is selected from the group consisting of whole blood, serum, plasma, urine, sputum, bronchial lavage fluid, tears, nipple aspirate, lymph, saliva, fine needle aspirate, and combinations thereof.

10. The kit of claim 8 , wherein the isolated cells are selected from the group consisting of circulating tumor cells, circulating endothelial cells, circulating endothelial progenitor cells, cancer stem cells, tumor cells, and combinations thereof.

11. The kit of claim 8 , wherein the isolated cells are stimulated in vitro with growth factors.

12. The kit of claim 11 , wherein the isolated cells are lysed following growth factor stimulation to produce the cellular extract.

13. The kit of claim 6 , wherein the one or more analytes comprise a plurality of signal transduction molecules.

14. The kit of claim 6 , wherein the solid support is selected from the group consisting of glass, plastic, chips, pins, filters, beads, paper, membrane, fiber bundles, and combinations thereof.

15. A kit for performing an antibody-based array method, the kit comprising:

(a) a dilution series of a plurality of capture antibodies restrained on a solid support;

(b) a plurality of detection antibodies comprising activation state-independent antibodies and activation state-dependent antibodies, wherein the detection antibodies comprise a plurality of activation state-independent antibodies which are labeled with glucose oxidase, and a plurality of activation state-dependent antibodies labeled with a first member of a signal amplification pair, wherein the first member of the signal amplification pair is horseradish peroxidase, wherein glucose oxidase generates hydrogen peroxide (H 2 O 2 ), which channels to and reacts with horseradish peroxidase;

(c) a second member of the signal amplification pair, which is a tyramide reagent; and

(d) instructions for methods of using the kit to detect the activation states of a plurality of signal transduction molecules.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2014
From: HARVEY, JEANNE; SINGH, SHARAT; KIM, PHILLIP; LIU, XINJUN; BARHAM, ROBERT; LIU, LIMIN
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 032447/0067 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2014
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 032447/0114 →